当前位置:APASL-en-亚太肝脏研究协会年会 >> 正文
[APASL2014]Treatment end points of Hepatitis B:What they are and How to achieve?——Interview with Prof.Jia-Horng Kao
—— 作者:Jia-Horng_Kao 时间:2014-03-13
阅读数:
103
简介:The goal of antiviral treatment is to maximize the long-term inhibition of viral replication, thereby delaying the progress of liver disease and reducing the occurrence of liver cirrhosis, hepatocellular carcinoma (HCC), and liver failure.
请登录后查看详细内容
标签:
专家访谈
专家访谈
乙肝
发表评论
全部评论